ENGAGE: Podcasts

Chiesi believes that true ‘sustainability’ can only be achieved with a broad array of projects that protect both our patients and the planet. As such this defines our actions, and the way that we do business. In recognition to our commitment to sustainability, Chiesi is proud to have been recognised as a certified B Corp and committed in 2019 to becoming carbon neutral by the end of 2035 well ahead of the 2050 target set out in the Paris agreement – and 15 years ahead of the UK national target^1,2.

This podcast series aims to demystify the various terminology used when discussing carbon neutrality in relation to sustainable respiratory care, and explores the carbon footprint associated with sustainable respiratory care and what the health care community can do to be more environmentally focussed without limiting patient choice.

Asthma is a condition which affects different patients in different ways and can be challenging to manage. The national review of Asthma deaths¹ outlines 19 recommendations for Asthma care. This podcast series aims to discuss the first-hand experiences of the healthcare community working with some of these recommendations, and explores useful ideas on implementation with the aim of achieving enhanced asthma care.

Managing COPD is much more than ensuring a patient is prescribed inhalers. It requires a holistic approach to managing the condition, alongside other co- or multimorbidities the patient may have. In this podcast series, Chiesi have brought together the views from a wide range of healthcare professionals (hospital consultant, GP with specialist interest in respiratory, specialist nurse, specialist pharmacists, physiotherapist & respiratory epidemiologist) to explore topics that may help to optimise the care provided to COPD patients.

The first CFTR modulator became available on the NHS in December 2016 and was made available for around 5% of pwCF¹. In 2022, around 90% of pwCF² in the UK are suitable for CFTR modulator therapy.

Whilst there is no doubt CFTR modulators have positively and dramatically altered the disease pathway of cystic fibrosis^3-5, there remains a level of uncertainty around how to manage the changing clinical picture of cystic fibrosis alongside these transformational medicines. This podcast series is designed to discuss some of the challenges of ‘Life alongside CFTR modulators.’

The management of neonatal complications are complex and require a holistic approach, particularly for preterm infants who may be more vulnerable. There are many clinical challenges to consider in the first 24 hours of life for a neonate and these complications require round-the-clock care from a team of clinical experts. Chiesi has therefore brought together a panel of consultant neonatologists with specific expertise in some of the clinical challenges that neonates face in their first 24 hours of life.